Patient preferences for intervention in the setting of precursor multiple myeloma

Blood Cancer J. 2024 Oct 14;14(1):175. doi: 10.1038/s41408-024-01161-0.

Catherine R Marinac^{1

2}, Katelyn Downey³, Jacqueline Perry³, Brittany Fisher-Longden³, Timothy R Rebbeck^{3

4

5}, Urvi A Shah⁶, Elizabeth K O'Donnell^{3

4}, Irene M Ghobrial^{3

4}, Omar Nadeem^{3

4}, Brian L Egleston⁷

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, US. [email protected].
² Centers for Early Detection and Interception, Dana-Farber Cancer Institute, Boston, MA, US. [email protected].
³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, US.
⁴ Centers for Early Detection and Interception, Dana-Farber Cancer Institute, Boston, MA, US.
⁵ Zhu Family Center for Global Cancer Prevention, Harvard T.H. Chan School of Public Health, Boston, MA, US.
⁶ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, US.
⁷ Fox Chase Cancer Center, Philadelphia, PA, US.

No abstract available

Publication types